Gould, W.L.: Discussion of interchange of hormones. Mod. Med., 26: 28, 1958.
2.
Gould, W.L.: A new therapeutic approach to aging. Clin. Med., 4: 865, 1957.
3.
Master, A.M. : Angina pectoris, a 30-year progress report . J. A. M. A., 162: 1542, 1956.
4.
Oliver, M.F. , AND Boyd, G.S.: Endocrine aspects of coronary sclerosis . Lancet, 2: 1273, 1956.
5.
Barr, D.P.: Coronary heart disease, address to American College of Physicians . J. A. M. A., 164: 488, 1957.
6.
Barr, D.P.: Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasma. J. Chron. Dis., 1: 63, 1955.
7.
Kask, E.: 17-Ketosteroid deficiency related to arteriosclerosis. Angiology, 10: 358, 1959.
8.
Lesser, M.A. : Testosterone propionate therapy in 100 cases of angina pectoris. J. Clin. Endocrinol., 6: 549, 1946.
9.
Levine, E.B. , AND Sellers, A.L.: Testosterone in angina pectoris. Am. J. M. Sci., 212: 7, 1946.
10.
Melville, K.I. : Androgens, in Drill's Pharmacology in Medicine, Ed. 2, p. 500. Blakiston, New York, 1958.
11.
Russ, E.M., Eder, H.A., AND Barr, D.P.: Influence of gonadal hormones on protein-lipid relationships in human plasma . Am. J. Med., 19: 4, 1955.
12.
Bonner, C.D. , Homburger, F., Smithy , G.B., AND Borges, P.R.F.: "Prostatic" serum acid phosphatase level in cancer of the prostate, diagnostic and clinical significance as illustrated by 13 case histories. J. A. M. A., 164: 1070, 1957 .
13.
Goodman, L.S. , AND Gilman, A.: Pharmacological Basis of Therapeutics , Ed. 2, p. 1616. Macmillan, New York, 1955.
14.
Queries AND Minor Notes: Androgen-estrogen therapy. J. A. M. A., 164: 1524, 1957 .
15.
Pick, R., Stamler, J., Rodbard, S., AND Katz, L.N.: Inhibition of coronary atherosclerosis by estrogens in cholesterol-fed chicks . Circulation, 6: 276, 1952.
16.
Pick, R., Stamler, J., Rodbard, S., AND Katz, L.N.: Estrogen-induced regression of coronary atherosclerosis in cholesterol-fed chicks. Circulation, 6: 858, 1952.
17.
Drill, V.A.: Treatment of atherosclerosis with estrogens, in Drill's Pharmacology in Medicine, Ed. 2, p. 923. Blakiston, New York, 1958.
18.
Robinson, R.W. , Cohen, W.D., AND Higano, N. .: Estrogen replacement therapy in women with coronary atherosclerosis. Ann. Int. Med., 48: 95, 1958.
19.
Council ONDrugs Of A.M.A.: New and Nonofficial Drugs, pp. 625-626. J. B. Lippincott , Philadelphia, 1961.
20.
Wallach, S., AND Henneman, P.H., Prolonged estrogen therapy in postmenopausal women, J. A. M. A., 171: 1637, 1959.
21.
Oliver, B.B. , AND Friedman. B.: Effect of estrogen therapy on patients with angina pectoris. Am. J. M. Sci.,231: 205, 1956 .
22.
Marmorston, J., Magdison, O., Kuzma , O., AND Moore, F.J.: Estrogen therapy in men with myocardial infarction, side-effects with increasing dosage and time. J. A. M. A., 174: 241, 1960.
23.
Robinson, R.W. , Higano, N., Cohen , W.D., Sniffen, R.C., AND Sherer, J.W., JR.: Effects of estrogen therapy on hormonal functions and serum lipids in men with coronary atherosclerosis. Circulation,14: 365, 1956.
24.
United States Pharmacopeia XVI, p. xxxix. U. S. Pharmacopeial Convention , Washington, 1960.
25.
Council On Drugs Of A. M. A.: New and NonofficialDrugs, p. 674. J. B. Lippincott, Philadelphia, 1961.
26.
Simeons, A.T.W. : Chorionic gonadotropin in geriatrics. J. Am. Geriatrics Soc., 4: 36, 1956.
27.
Mosetti, A. , AND Nodari, G.: Chorionic gonadotropin in cardiovascular affections. Minerva cardioangiol.,58: 314, 1957.
28.
Gould, W.L. : The male climacteric, report of a series of 120 cases using fortified gonadotropic hormone. M. Times, 79: 154, 1951.
29.
Martin, E.W. , AND Cook, E.F.: Remington's Practice of Pharmacy, Ed. 11, p. 1061. Mack, Easton, Pa., 1956.
30.
Strosberg, I., AND Damrau, F.: Impotence and male climacteric, evaluation of fortified chorionic gonadotropin. Exper. Med. & Surg.,18: 371, 1960.
31.
Milhoan, A.W. : Heterosexual vs. homosexual hormonesTri-State M. J.,6: 11, 1958.
32.
Etter, E.A. : Hypogonadal impotence in middle-aged men, treatment with fortified chorionic gonadotropin. ArizonaMed., 17: 217, 1960.
33.
Robinson, H.R. : Gonadal stimulation for impotence. M. Rec. & Ann.,53: 94, 1960.
34.
Browning, W.J. : Male climacteric and impotence, value of gonadal stimulation. Internat. Rec. Med., 173: 690, 1960 .
35.
Wilkinson, C.F., JR.: Drugs other than anticoagulants in treatment of arteriosclerotic heart disease. J. A. M. A.,163: 927, 1957.
36.
Gould, W.L. : Auricular fibrillation, report on a study of a familial tendency, 1920-56. A. M. A. Arch. Int. Med. , 100: 916, 1957.
37.
Gould, W.L. , AND Strosberg, I.: Male senility, report of a series of 237 cases using fortified gonadotropin. M. Times, 79: 622, 1961.
38.
Damrau, F.: Evaluation of treatment with fortified chorionic gonadotropin with special reference to disease conditions in elderly subjects. J. Gerontol. , 16: 33, 1961.
39.
Goode, P., AND Damrau, F.: Heterologous sex hormone therapy and the geriatric-psychiatric patient with an organic psychosis, of the senile psychotic type and the cerebral arteriosclerotic type, in a hospital setting. J. Neuropsychiat., in press.
40.
Sollmann, T. : Manual of Pharmacology, Ed. 8, pp. 621-623. W. B. Saunders, Philadelphia, 1957.
41.
Gould, W.L. , AND Strosberg, I.: Female senility, report of a series of 217 cases using a new fortified androgen. New YorkJ. Med. , 53: 661, 1953.
42.
National Formulary, XI, p. 362. American Pharmaceutical Association, Washington, 1960.
43.
Isachsen, N.O. , AND Lombard, F.A.: Geriatric use of sex hormones in veterinary medicine. Vet. Med., 55: 63, 1960.
44.
Fobian, V.C. : Endocrine therapy for stale race horses, fortified sex hormones improve performances. Vet. Med., 56: 30, 1961.